{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:17:57Z","timestamp":1770823077820,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1067\/mjd.2003.78","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T20:26:11Z","timestamp":1042143971000},"page":"55-60","source":"Crossref","is-referenced-by-count":133,"title":["Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)"],"prefix":"10.1067","volume":"48","author":[{"given":"Julian M.","family":"Mackay-Wiggan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc E.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2003.78_bib1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.78_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000372-200110000-00001","article-title":"Nephrogenic fibrosing dermopathy","volume":"23","author":"Cowper","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1067\/mjd.2003.78_bib3","first-page":"569","article-title":"Fibromes miliaires folliculaires: sclerodermie consecutive","volume":"37","author":"Dubreuilh","year":"1906","journal-title":"Ann Dermatol Syphil"},{"key":"10.1067\/mjd.2003.78_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01949029","article-title":"Uber eine eigenartige, der sklerodermie nahestehende affection","volume":"92","author":"Reitman","year":"1908","journal-title":"Arch Dermatol Syphil"},{"key":"10.1067\/mjd.2003.78_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jid.1953.25","article-title":"Lichen myxedematosus (differentiation from cutaneous myxedemas or mucoid states)","volume":"20","author":"Montgomery","year":"1953","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2003.78_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00362184","article-title":"Skleromyx\u00f6dem (eine eigenartige euscheinungsform von myxothesaurodermie)","volume":"199","author":"Gottron","year":"1954","journal-title":"Arch Dermatol Syphil"},{"key":"10.1067\/mjd.2003.78_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(98)70567-5","article-title":"Fatal scleromyxedema: report of a case and review of the literature","volume":"38","author":"Godby","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(86)70001-7","article-title":"The cutaneous mucinoses","volume":"14","author":"Truhan","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","article-title":"Scleromyxedema","volume":"33","author":"Dinneen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.622555","article-title":"Lichen myxedematosus serum stimulates human skin fibroblast proliferation","volume":"199","author":"Harper","year":"1978","journal-title":"Science"},{"key":"10.1067\/mjd.2003.78_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archderm.1979.04010030003002","article-title":"Treatment of scleromyxedema with melphalan","volume":"115","author":"Harris","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib12","first-page":"60","article-title":"Scleromyxedema associated with esophageal aperistalsis and dermal eosinophilia","volume":"28","author":"Alligood","year":"1981","journal-title":"Cutis"},{"key":"10.1067\/mjd.2003.78_bib13","first-page":"69","article-title":"Scleromyxedema","volume":"23","author":"Findlay","year":"1960","journal-title":"S Afr Med J"},{"key":"10.1067\/mjd.2003.78_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archderm.1964.01590270132030","article-title":"An abnormal serum globulin in lichen myxedematosus","volume":"89","author":"McCarthy","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.1994.01690010045005","article-title":"Fibrogenic growth factors in the eosinophilia myalgia syndrome and the toxic oil syndrome","volume":"130","author":"Kaufman","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib16","first-page":"1133","article-title":"Cutaneous eosinophilic diseases","author":"Leiferman","year":"1999"},{"key":"10.1067\/mjd.2003.78_bib17","first-page":"806","article-title":"Eosinophilia myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead","volume":"7","author":"Sidransky","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1067\/mjd.2003.78_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0190-9622(96)90347-3","article-title":"Delayed onset of skin fibrosis after the ingestion of eosinophilia myalgia syndrome-associated L-tryptophan","volume":"35","author":"Greenburg","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib19","first-page":"2023","article-title":"Scleroderma","author":"Tu","year":"1999"},{"key":"10.1067\/mjd.2003.78_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(87)70251-5","article-title":"Frequency levels and significance of blood eosinophilia in systemic sclerosis, localized scleroderma and eosinophilic fasciitis","volume":"17","author":"Falanga","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib21","first-page":"116","article-title":"A large prospective survey of anti-cardiolipin antibodies in chronic hemodialysis patients","volume":"51","author":"Valeri","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1067\/mjd.2003.78_bib22","first-page":"89","article-title":"Antiphospholipid (aPL) antibodies in end-stage renal disease","volume":"12","author":"Fabrizi","year":"1999","journal-title":"J Nephrol"},{"key":"10.1067\/mjd.2003.78_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0190-9622(91)70132-L","article-title":"Improvement of scleromyxedema associated with isotretinoin therapy","volume":"24","author":"Hisler","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0190-9622(88)70199-1","article-title":"Scleromyxedema: therapeutic response to isotretinoin in three patients","volume":"19","author":"Milam","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0190-9622(84)80230-3","article-title":"Treatment of scleromyxedema with etretinate","volume":"10","author":"Brenner","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(08)81176-0","article-title":"Successful treatment of scleromyxedema with plasmapheresis and immunosuppression","volume":"22","author":"Keong","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archderm.1987.01660300108022","article-title":"Plasmapheresis in a patient with scleromyxedema","volume":"123","author":"Westheim","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib28","first-page":"38","article-title":"Scleromyxedema: complete response to extracorporeal photopheresis and steroids","volume":"128","author":"D'Incan","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1067\/mjd.2003.78_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0190-9622(08)80676-7","article-title":"Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedema","volume":"25","author":"Berkson","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archderm.1969.01610190057010","article-title":"Scleromyxedema: a dramatic response to melphalan","volume":"99","author":"Feldman","year":"1969","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.1980.01640320012005","article-title":"Melphalan therapy in the treatment of scleromyxedema","volume":"116","author":"Chanda","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-4362.1978.tb05989.x","article-title":"Lichen myxedematosus: treatment with cyclophosphamide","volume":"17","author":"Jessen","year":"1978","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2003.78_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0190-9622(99)70471-8","article-title":"Scleromyxedema: treatment with interferon alfa","volume":"40","author":"Tschen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0190-9622(00)70305-7","article-title":"Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg)","volume":"43","author":"Lister","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0190-9622(96)90650-7","article-title":"Treatment of scleromyxedema with 2-chlorodeoxyadenosine","volume":"35","author":"Davis","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.78_bib36","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archderm.1991.01680100137029","article-title":"Regression of scleromyxedema with topical betamethasone and dimethylsulfoxide: a 30 month follow-up","volume":"127","author":"Bonnetblanc","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2003.78_bib37","first-page":"321","article-title":"Scleromyxedema: systemic manifestations and cosmetic improvement from dermabrasion","volume":"39","author":"Kaufman","year":"1987","journal-title":"Cutis"},{"key":"10.1067\/mjd.2003.78_bib38","first-page":"25","volume":"51","year":"2002","journal-title":"MMWR\/Morb Mortal Wkly Rep"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203500111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203500111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T13:26:13Z","timestamp":1553952373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962203500111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0190962203500111"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2003.78","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}